Association between antibiotic usage during infancy and asthma incidence among children: a population-level ecological study in British Columbia, Canada.

IF 3.3 Q2 ALLERGY Frontiers in allergy Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI:10.3389/falgy.2024.1456077
Abdullah Al Mamun, Carl Zou, Hannah Lishman, Säde Stenlund, Max Xie, Erica Chuang, David M Patrick
{"title":"Association between antibiotic usage during infancy and asthma incidence among children: a population-level ecological study in British Columbia, Canada.","authors":"Abdullah Al Mamun, Carl Zou, Hannah Lishman, Säde Stenlund, Max Xie, Erica Chuang, David M Patrick","doi":"10.3389/falgy.2024.1456077","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study follows published associations in BC to 2014 (updated in 2019) to model the predicted incidence of asthma in BC children attributable to antibiotic use within the context of reduced antibiotic use and increased breastfeeding in BC infants from 2000 to 2019.</p><p><strong>Methods: </strong>A population-based ecological study was conducted in BC from 2000 to 2019, using outpatient antibiotic prescription data from BC PharmaNet and asthma diagnoses from the Chronic Disease Registry. Breastfeeding estimates were calculated using the Canadian Community Health Survey (CCHS). Population attributable risk (PAR) was calculated using a blended relative risk (RR) of asthma in antibiotic-exposed children who were and were not breastfed. PAR was used to calculate predicted vs. actual asthma incidence in 2019. Negative binomial regression was used to estimate the association between the average antibiotic prescription rate in infants under 1 and asthma incidence in 1-4 year olds, stratified by periods between 2000-2014 and 2015-2019.</p><p><strong>Results: </strong>In BC, antibiotic prescribing decreased by 77% in infants under 1 and asthma incidence decreased by 41% in children 1-4 years from 2000 to 2019. BC breastfeeding rates increased from 46% in the 2005 CCHS to 71% in the 2017/18 CCHS. After calculating the PAR using a blended RR, the predicted asthma incidence in 2019 was 18.8/1,000 population. This was comparable to the observed asthma incidence in children 1-4 years of 16.6/1,000 population in 2019. During 2000-2014, adjusted incidence risk ratio (aIRR) for children under Quintile 5 of average antibiotic prescribing was 1.75 (95% CI: 1.63-1.88, <i>P</i> < 0.0001) times higher than that for Quintile 1. However, between 2015 and 2019, this association weakened (as expected because of increasing prevalence of breastfeeding), with the expected asthma incidence for Quintile 5 only 11% (aIRR 1.11, 95% CI: 0.78-1.57) higher than for Quintile 1.</p><p><strong>Conclusion: </strong>We identified that over the past 20 years, antibiotic exposure in infants under 1 and asthma incidence in children 1-4 years has decreased significantly. Decreasing antibiotic exposure and increasing breastfeeding (which further mitigates risk associated with antibiotics) are of sufficient scale to explain much of this population trend. Changes in environmental, social and other exposures remain relevant to this complicated etiological pathway.</p>","PeriodicalId":73062,"journal":{"name":"Frontiers in allergy","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11403638/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/falgy.2024.1456077","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study follows published associations in BC to 2014 (updated in 2019) to model the predicted incidence of asthma in BC children attributable to antibiotic use within the context of reduced antibiotic use and increased breastfeeding in BC infants from 2000 to 2019.

Methods: A population-based ecological study was conducted in BC from 2000 to 2019, using outpatient antibiotic prescription data from BC PharmaNet and asthma diagnoses from the Chronic Disease Registry. Breastfeeding estimates were calculated using the Canadian Community Health Survey (CCHS). Population attributable risk (PAR) was calculated using a blended relative risk (RR) of asthma in antibiotic-exposed children who were and were not breastfed. PAR was used to calculate predicted vs. actual asthma incidence in 2019. Negative binomial regression was used to estimate the association between the average antibiotic prescription rate in infants under 1 and asthma incidence in 1-4 year olds, stratified by periods between 2000-2014 and 2015-2019.

Results: In BC, antibiotic prescribing decreased by 77% in infants under 1 and asthma incidence decreased by 41% in children 1-4 years from 2000 to 2019. BC breastfeeding rates increased from 46% in the 2005 CCHS to 71% in the 2017/18 CCHS. After calculating the PAR using a blended RR, the predicted asthma incidence in 2019 was 18.8/1,000 population. This was comparable to the observed asthma incidence in children 1-4 years of 16.6/1,000 population in 2019. During 2000-2014, adjusted incidence risk ratio (aIRR) for children under Quintile 5 of average antibiotic prescribing was 1.75 (95% CI: 1.63-1.88, P < 0.0001) times higher than that for Quintile 1. However, between 2015 and 2019, this association weakened (as expected because of increasing prevalence of breastfeeding), with the expected asthma incidence for Quintile 5 only 11% (aIRR 1.11, 95% CI: 0.78-1.57) higher than for Quintile 1.

Conclusion: We identified that over the past 20 years, antibiotic exposure in infants under 1 and asthma incidence in children 1-4 years has decreased significantly. Decreasing antibiotic exposure and increasing breastfeeding (which further mitigates risk associated with antibiotics) are of sufficient scale to explain much of this population trend. Changes in environmental, social and other exposures remain relevant to this complicated etiological pathway.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
婴儿期使用抗生素与儿童哮喘发病率之间的关系:加拿大不列颠哥伦比亚省的一项人群生态研究。
背景:本研究沿用不列颠哥伦比亚省截至 2014 年(2019 年更新)已公布的关联,在 2000 年至 2019 年不列颠哥伦比亚省婴儿抗生素使用减少和母乳喂养增加的背景下,对不列颠哥伦比亚省儿童因抗生素使用而导致的哮喘发病率进行预测建模:方法:利用不列颠哥伦比亚省制药网(BC PharmaNet)提供的门诊抗生素处方数据和慢性病登记处提供的哮喘诊断数据,在不列颠哥伦比亚省开展了一项基于人口的生态研究(2000-2019 年)。母乳喂养估计值通过加拿大社区健康调查(CCHS)计算得出。使用混合相对风险 (RR) 计算暴露于抗生素的母乳喂养和非母乳喂养儿童的哮喘人群归因风险 (PAR)。PAR 用于计算 2019 年哮喘的预测发病率与实际发病率。负二项回归用于估计1岁以下婴儿的平均抗生素处方率与1-4岁儿童哮喘发病率之间的关系,按2000-2014年和2015-2019年期间进行分层:在不列颠哥伦比亚省,从2000年到2019年,1岁以下婴儿的抗生素处方减少了77%,1-4岁儿童的哮喘发病率减少了41%。不列颠哥伦比亚省的母乳喂养率从2005年CCHS的46%上升至2017/18年CCHS的71%。使用混合 RR 计算 PAR 后,预测 2019 年的哮喘发病率为 18.8/1,000 人。这与2019年观察到的1-4岁儿童哮喘发病率16.6/1,000人相当。2000-2014 年间,五分位数 5 以下儿童平均抗生素处方的调整后发病风险比(aIRR)为 1.75(95% CI:1.63-1.88,P 结论):我们发现,在过去的 20 年中,1 岁以下婴儿的抗生素接触率和 1-4 岁儿童的哮喘发病率显著下降。抗生素接触的减少和母乳喂养的增加(进一步降低了与抗生素相关的风险)足以解释这一人口趋势。环境、社会和其他暴露的变化仍然与这一复杂的病因途径有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms. Diagnosis and management of shrimp allergy. When allergies have no name: is idiopathic anaphylaxis driven by co-factors? Allergenic protein-induced type I hypersensitivity models: a review. Key differences between chronic inducible and spontaneous urticaria.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1